ANDA 70738, held by Hospira. Verapamil Hydrochloride.
As of Nov 16, 2026, ANDA 70738 (Verapamil Hydrochloride), held by Hospira, was first approved by FDA on May 6, 1987, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 6, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Verapamil Hydrochloride5MG/2ML (2.5MG/ML) · solution;intravenous | Verapamil Hydrochloride | Rx |
| Dec 20, 2021 | Supplement 16Labeling · Standard review | Approved | None posted |
| Dec 20, 2021 | Supplement 17Labeling · Standard review | Approved | None posted |
| Dec 9, 1998 | Supplement 8Manufacturing | Approved | None posted |
| Mar 26, 1998 | Supplement 4Labeling | Approved | None posted |
| Oct 3, 1996 | Supplement 6Manufacturing | Approved | None posted |
| Apr 17, 1991 | Supplement 3Labeling | Approved | None posted |
| May 17, 1990 | Supplement 1Manufacturing | Approved | None posted |
| Feb 16, 1990 | Supplement 2Labeling | Approved | None posted |
| May 6, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters